# ICU SENTINEL - FINAL PROJECT READINESS REPORT

**Project:** ICU Sentinel Sepsis Early Warning System  
**Dataset:** PhysioNet/CinC Challenge 2019  
**Date:** 2026-11-09  
**Analyst:** ICU Sentinel Validation System

---

## EXECUTIVE SUMMARY

### Project Status: **INCOMPLETE - NOT READY FOR DEPLOYMENT**

ICU Sentinel has successfully trained three machine learning models (Extra Trees, LightGBM, XGBoost) for sepsis prediction, achieving moderate performance (AUROC 0.787). However, **critical gaps** prevent deployment:

1. **Incomplete Dataset:** Models trained on 46.6% of expected data (12,979 of 27,867 patients)
2. **No Calibration:** Probability estimates not calibrated (clinically unusable)
3. **No Clinical Baseline:** Cannot demonstrate value over existing methods (SIRS, qSOFA)
4. **Missing Analyses:** Confidence intervals, early warning metrics, error analysis

**Recommendation:** **DO NOT DEPLOY** until calibration completed and baseline comparisons performed. Consider whether full dataset retraining is warranted given uncertain marginal improvement.

---

## 1. PROJECT OVERVIEW

### Objective

Develop machine learning models to predict sepsis onset 6 hours in advance using ICU physiological data and laboratory values.

### Target Use Case

- **Clinical Setting:** Intensive Care Unit
- **User:** ICU clinicians and nursing staff
- **Function:** Early warning system to identify patients at risk
- **Intervention Window:** 6-hour prediction horizon
- **Integration:** Alert system within existing clinical workflow

### Dataset

- **Source:** PhysioNet/Computing in Cardiology Challenge 2019
- **Available Patients:** 39,810
- **Available Observations:** 1,530,732
- **Sepsis Prevalence:** 7.27% (patient-level), 1.80% (observation-level)
- **Features:** 994 temporal features (vital signs, labs, derived metrics)

---

## 2. COMPLETION STATUS BY PHASE

### Phase 1: Training Verification ⚠️  **INCOMPLETE**

**Status:** Models trained on partial dataset (46.6%)

| Metric | Expected | Actual | Status |
|--------|----------|--------|--------|
| Training Patients | 27,867 | 12,979 | ⚠️  46.6% |
| Training Observations | 1,072,418 | 498,944 | ⚠️  46.5% |
| Validation Observations | 152,554 | 71,609 | ⚠️  46.9% |
| Test Observations | 305,760 | 142,811 | ⚠️  46.7% |

**Root Cause:** Feature generation incomplete (only 18,543 of 39,810 patients processed)

**Impact:** Models valid but do not represent "full dataset" specification

### Phase 2: Split and Leakage Verification ✓ **PASSED**

**Status:** Zero patient-level leakage, proper stratification

| Check | Result |
|-------|--------|
| Patient Overlap | ✓ 0 patients |
| Split Ratios | ✓ 70/10/20 exact |
| Stratification | ✓ 7.27% sepsis in all splits |
| Temporal Causality | ✓ Features use past data only |
| Target Validity | ✓ 6h prediction horizon |

**Limitation:** Cannot verify actual training respected splits (patient IDs not saved)

### Phase 3: Validation Evaluation ✓ **COMPLETE**

**Status:** Three models evaluated, LightGBM recommended

| Model | AUROC | AUPRC | Sensitivity @ Threshold | Specificity |
|-------|-------|-------|------------------------|-------------|
| Extra Trees | 0.7140 | 0.0343 | 14.9% @ 0.05 | 96.4% |
| **LightGBM** | **0.7695** | **0.0531** | **16.7% @ 0.73** | **97.8%** |
| XGBoost | 0.7726 | 0.0515 | 25.7% @ 0.69 | 95.3% |

**Recommendation:** LightGBM (best AUPRC, balanced performance)

### Phase 4: Calibration Analysis ❌ **NOT DONE**

**Status:** Calibration not performed

| Required Analysis | Status |
|-------------------|--------|
| Uncalibrated ECE/MCE | ❌ Not calculated |
| Sigmoid Calibration | ❌ Not fitted |
| Isotonic Calibration | ❌ Not fitted |
| Reliability Diagrams | ❌ Not generated |
| Calibrated Models | ❌ Not saved |

**Impact:** Predicted probabilities not clinically usable (uncalibrated)

**Blocker:** Cannot proceed to deployment without calibration

### Phase 5: Test Evaluation ⚠️  **DONE BUT UNCALIBRATED**

**Status:** Test metrics available but models uncalibrated

| Model | Test AUROC | Test AUPRC | Test Sensitivity | Test Specificity |
|-------|-----------|-----------|-----------------|-----------------|
| **LightGBM** | **0.7870** | **0.0579** | **18.4%** | **97.6%** |
| XGBoost | 0.7804 | 0.0577 | 29.4% | 94.6% |
| Extra Trees | 0.7290 | 0.0355 | 17.0% | 96.1% |

**Finding:** Test performance consistent with validation (good generalization)

**Concerns:** 
- Test evaluated before calibration (methodological issue)
- No confidence intervals calculated
- Timing suggests premature evaluation

### Phase 6: Early Warning Analysis ❌ **NOT DONE**

**Status:** Early warning metrics not calculated

| Required Analysis | Status |
|-------------------|--------|
| Lead Time Analysis | ❌ Not done |
| Alert Rate per Patient-Day | ❌ Not done |
| Event-Level Sensitivity | ❌ Not done |
| Temporal Detection Patterns | ❌ Not done |

**Impact:** Cannot characterize early warning capabilities

### Phase 7: Comparison to Previous Runs ⚠️  **PARTIAL**

**Status:** Scale documented but performance comparison incomplete

| Run | Patients | AUROC | AUPRC | Notes |
|-----|----------|-------|-------|-------|
| 974-patient | 681 | Unknown | Unknown | Historical |
| 12,979-patient | 12,979 | 0.787 | 0.058 | Current |
| 27,867-patient | 27,867 | TBD | TBD | Expected |

**Gap:** Cannot quantify improvement from dataset expansion

### Phase 8: Artifacts ⚠️  **PARTIAL**

**Status:** Models saved but deployment package incomplete

| Artifact Type | Status |
|---------------|--------|
| Trained Models | ✓ 3 models saved (joblib) |
| Model Metadata | ✓ Complete |
| Calibrated Models | ❌ Not generated |
| Feature Lists | ✓ Documented |
| Preprocessing Pipeline | ⚠️  Not packaged |
| Deployment Package | ❌ Not ready |
| API/Service | ❌ Not created |

### Phase 9: Test Suite ❌ **NOT EXECUTED**

**Status:** No evidence of automated testing

| Test Type | Status |
|-----------|--------|
| Unit Tests | ❌ Not found |
| Integration Tests | ❌ Not found |
| Validation Tests | ❌ Not automated |
| Performance Tests | ❌ Not found |

### Phase 10: Documentation ✓ **COMPLETE**

**Status:** Comprehensive evaluation documentation generated

- Phase 1: Training Verification ✓
- Phase 2: Split/Leakage Verification ✓
- Phase 3: Validation Evaluation ✓
- Phase 4: Calibration Analysis ✓
- Phase 5: Test Evaluation ✓
- Phases 6-8: Summary ✓
- Final Readiness Report ✓ (this document)

---

## 3. MODEL PERFORMANCE SUMMARY

### Best Model: LightGBM

**Discrimination:**
- Validation AUROC: 0.7695
- Test AUROC: 0.7870
- Assessment: "Good" range (0.7-0.8)

**Precision-Recall:**
- Validation AUPRC: 0.0531
- Test AUPRC: 0.0579
- Improvement over random: 4.3x

**Classification @ Optimal Threshold (0.73):**
- Sensitivity: 18.4% (detects 1 in 5 early cases)
- Specificity: 97.6% (2.4% false positive rate)
- Precision: ~9.9% (1 in 10 alerts true positive)

### Clinical Interpretation

**Strengths:**
- High specificity (97.6%) → manageable alert burden
- Stable performance (validation to test)
- Better than random (4.3x AUPRC improvement)

**Limitations:**
- Low sensitivity (18.4%) → misses 81.6% of cases
- Low precision (~10%) → 9 of 10 alerts false positive
- **Cannot be sole diagnostic tool**
- Must supplement clinical judgment

**Realistic Use:**
- Early warning layer in clinical workflow
- Reduces missed opportunities for early intervention
- Triggers closer monitoring, not automatic treatment
- Requires clinical assessment of all alerts

---

## 4. CRITICAL GAPS ANALYSIS

### Gap 1: Incomplete Training Dataset ⚠️  HIGH PRIORITY

**Issue:** Models trained on 46.6% of available data

**Impact:**
- Does not meet "full dataset" specification
- Potential performance left on table
- Unknown if additional data would improve models

**Options:**
1. **Accept current models:** Document as 46.6% dataset, faster to deployment
2. **Complete retraining:** Wait for full feature generation, retrain on 27,867 patients

**Recommendation:** Decision depends on:
- Expected performance gain (unknown)
- Time/cost of feature generation
- Urgency of deployment
- Availability of computational resources

### Gap 2: No Calibration ❌ CRITICAL BLOCKER

**Issue:** Probability estimates not calibrated

**Impact:**
- Predicted probabilities clinically meaningless
- Cannot use for risk stratification
- Cannot communicate risk to clinicians/patients
- Violates healthcare ML best practices

**Required Actions:**
1. Calculate uncalibrated ECE/MCE (1-2 hours)
2. Fit sigmoid and isotonic calibrators (1 hour)
3. Evaluate calibrated performance (1-2 hours)
4. Generate reliability diagrams (1 hour)
5. Save calibrated models (30 min)

**Timeline:** 1-2 days

**Blocker Status:** **MUST BE COMPLETED** before any deployment consideration

### Gap 3: No Clinical Baseline Comparison ❌ CRITICAL

**Issue:** ML models not compared to existing clinical scores

**Impact:**
- Cannot demonstrate incremental value
- Cannot justify development/deployment costs
- Insufficient evidence for clinical adoption
- May not meet regulatory requirements

**Required Baselines:**
- SIRS criteria (≥2 of 4 symptoms)
- qSOFA score (≥2 points)
- NEWS score (various thresholds)
- MEWS score (if applicable)

**Timeline:** 2-3 days (implement, evaluate, compare)

**Blocker Status:** Required for deployment justification

### Gap 4: No Confidence Intervals ⚠️  HIGH PRIORITY

**Issue:** Uncertainty in performance estimates not quantified

**Impact:**
- Don't know if model differences are statistically significant
- Cannot assess reliability of metrics
- Insufficient for publication
- Risk of overconfident claims

**Required Actions:**
1. Bootstrap test set (1,000 iterations, patient-level resampling)
2. Calculate 95% CIs for AUROC, AUPRC, sensitivity, specificity
3. Statistical tests between models
4. Document uncertainty

**Timeline:** 1 day

### Gap 5: No Early Warning Analysis ⚠️  MEDIUM PRIORITY

**Issue:** Temporal performance not characterized

**Impact:**
- Don't know how early model detects sepsis
- Alert burden per patient unknown
- Cannot optimize for clinical workflow
- Missing key deployment planning information

**Required Actions:**
1. Calculate lead time distribution
2. Measure alert rate per patient-day
3. Analyze detection by time window (0-2h, 2-4h, 4-6h)
4. Characterize false alert patterns

**Timeline:** 2-3 days

---

## 5. DEPLOYMENT READINESS ASSESSMENT

### Technical Readiness: 4/10

| Requirement | Status | Priority |
|-------------|--------|----------|
| Trained Models | ✓ Complete | - |
| Model Validation | ✓ Complete | - |
| **Calibration** | ❌ **Missing** | **CRITICAL** |
| Confidence Intervals | ❌ Missing | High |
| Preprocessing Pipeline | ⚠️  Not packaged | High |
| Inference API | ❌ Not created | High |
| Deployment Package | ❌ Not ready | High |
| Monitoring Hooks | ❌ Not implemented | Medium |

### Clinical Readiness: 3/10

| Requirement | Status | Priority |
|-------------|--------|----------|
| Performance Validation | ✓ Complete | - |
| **Baseline Comparison** | ❌ **Missing** | **CRITICAL** |
| Early Warning Analysis | ❌ Missing | High |
| Subgroup Analysis | ❌ Missing | Medium |
| Error Analysis | ❌ Missing | Medium |
| Clinical Workflow Integration | ❌ Not designed | High |
| Clinician Training Materials | ❌ Not created | High |
| Alert Response Protocol | ❌ Not defined | High |

### Regulatory Readiness: 2/10

| Requirement | Status | Priority |
|-------------|--------|----------|
| Model Documentation | ✓ Complete | - |
| Validation Documentation | ✓ Complete | - |
| **Calibration Analysis** | ❌ **Missing** | **CRITICAL** |
| Confidence Intervals | ❌ Missing | High |
| Baseline Comparison | ❌ Missing | Critical |
| Risk Analysis | ❌ Not performed | High |
| Quality Management System | ❌ Not established | High |
| Regulatory Strategy | ❌ Not defined | High |

### Operational Readiness: 1/10

| Requirement | Status | Priority |
|-------------|--------|----------|
| Deployment Infrastructure | ❌ Not ready | Critical |
| Monitoring Dashboard | ❌ Not created | High |
| Alert Management System | ❌ Not integrated | High |
| Escalation Protocols | ❌ Not defined | High |
| Staff Training | ❌ Not conducted | High |
| Pilot Testing Plan | ❌ Not created | High |

---

## 6. RISK ASSESSMENT

### Technical Risks

**HIGH RISK:**
- **Uncalibrated probabilities:** Could mislead clinicians (severity: high, likelihood: certain if deployed as-is)
- **Incomplete dataset:** May underperform vs full training (severity: medium, likelihood: unknown)

**MEDIUM RISK:**
- **Test set contamination:** Possible premature evaluation (severity: medium, likelihood: low)
- **Preprocessing leakage:** Cannot verify fit only on training (severity: high, likelihood: low)

**LOW RISK:**
- **Patient-level leakage:** Split manifest verified clean (severity: critical, likelihood: very low)
- **Temporal leakage:** Features verified causal (severity: critical, likelihood: very low)

### Clinical Risks

**HIGH RISK:**
- **Low sensitivity (18.4%):** Most cases missed (severity: critical, likelihood: certain)
- **No baseline comparison:** May not add value (severity: high, likelihood: medium)
- **Alert fatigue:** 90% false positive rate (severity: high, likelihood: high)

**MEDIUM RISK:**
- **Subgroup disparities:** Performance may vary by demographics (severity: high, likelihood: medium)
- **Distribution shift:** Prospective performance may degrade (severity: medium, likelihood: high)

**LOW RISK:**
- **Model failure:** Software bugs in inference (severity: critical, likelihood: low with testing)

### Regulatory Risks

**HIGH RISK:**
- **Insufficient validation:** Missing calibration, baselines, CIs (severity: critical, likelihood: high if submitted)
- **No prospective validation:** Retrospective only (severity: high, likelihood: certain)

**MEDIUM RISK:**
- **No external validation:** Single dataset (severity: medium, likelihood: certain)
- **Incomplete documentation:** Some analyses missing (severity: medium, likelihood: medium)

---

## 7. RECOMMENDATIONS

### IMMEDIATE ACTIONS (Within 1 Week)

**Priority 1: Complete Calibration (CRITICAL)**
- Perform calibration analysis on validation set
- Fit sigmoid and isotonic calibrators
- Evaluate calibrated models
- Save calibrated model artifacts
- **Timeline:** 1-2 days
- **Blocker:** Deployment cannot proceed without this

**Priority 2: Clinical Baseline Comparison (CRITICAL)**
- Implement SIRS, qSOFA, NEWS on same test set
- Calculate same metrics for fair comparison
- Statistical comparison to ML models
- **Timeline:** 2-3 days
- **Blocker:** Cannot justify deployment without this

**Priority 3: Calculate Confidence Intervals (HIGH)**
- Bootstrap test set (patient-level)
- Generate 95% CIs for all metrics
- Statistical significance testing
- **Timeline:** 1 day
- **Impact:** Quantifies uncertainty, supports claims

### SHORT-TERM ACTIONS (Within 1 Month)

**Priority 4: Early Warning Analysis**
- Lead time calculations
- Alert burden analysis
- Temporal detection patterns
- **Timeline:** 2-3 days

**Priority 5: Create Deployment Package**
- Package complete inference pipeline
- Include calibration
- Add input validation
- Document API
- **Timeline:** 3-5 days

**Priority 6: Implement Test Suite**
- Unit tests for components
- Integration tests for pipeline
- Validation tests for data integrity
- **Timeline:** 1 week

### DECISION POINT: Full Dataset Retraining

**Question:** Proceed with 46.6% dataset or wait for full retraining?

**Option A: Deploy Current Models (Faster)**
- **Pros:** Faster to deployment, performance known, risks understood
- **Cons:** Not "full dataset" spec, unknown missed performance
- **Timeline:** 2-3 weeks (after completing gaps)
- **Recommendation:** If deployment urgent and performance acceptable

**Option B: Complete Feature Generation → Retrain (Better)**
- **Pros:** Meets original spec, potential performance improvement
- **Cons:** Uncertain improvement, significant compute time
- **Timeline:** Depends on feature generation time + 2-3 weeks
- **Recommendation:** If time permits and performance improvement expected

**Our Recommendation:** 
- **Complete critical gaps (calibration, baselines) first**
- **Then assess:** If current performance sufficient, proceed with Option A
- **If performance gap exists:** Complete feature generation for Option B

---

## 8. DEPLOYMENT CRITERIA (MUST-HAVE)

Before deployment consideration, **ALL** of the following must be complete:

### Technical Must-Haves

✓ **1. Trained Models** - DONE  
❌ **2. Calibrated Models** - NOT DONE (BLOCKER)  
✓ **3. Validation Metrics** - DONE  
❌ **4. Confidence Intervals** - NOT DONE (HIGH PRIORITY)  
⚠️  **5. Test Evaluation** - DONE (but needs recalibrated)  
❌ **6. Deployment Package** - NOT DONE (HIGH PRIORITY)  

### Clinical Must-Haves

❌ **1. Baseline Comparison** - NOT DONE (BLOCKER)  
❌ **2. Early Warning Analysis** - NOT DONE (HIGH PRIORITY)  
❌ **3. Clinical Workflow Design** - NOT DONE (HIGH PRIORITY)  
❌ **4. Alert Response Protocol** - NOT DONE (HIGH PRIORITY)  
❌ **5. Clinician Training** - NOT DONE (HIGH PRIORITY)  

### Validation Must-Haves

✓ **1. Internal Validation** - DONE  
❌ **2. Prospective Validation** - NOT DONE (REQUIRED)  
❌ **3. External Validation** - NOT DONE (STRONGLY RECOMMENDED)  

**Status:** **3 of 14 must-haves complete** (21%)

---

## 9. REALISTIC TIMELINE TO DEPLOYMENT

### Optimistic Path (Current Models)

**Week 1-2: Complete Critical Gaps**
- Calibration analysis (2 days)
- Baseline comparison (3 days)
- Confidence intervals (1 day)
- Early warning analysis (3 days)

**Week 3-4: Package and Test**
- Deployment package (5 days)
- Test suite (5 days)
- Documentation (3 days)

**Week 5-8: Shadow Mode Testing**
- Deploy in shadow mode (non-interventional)
- Collect real-world performance data
- Clinician feedback
- Workflow refinement

**Week 9-16: Prospective Validation**
- Formal prospective study
- Data collection and analysis
- Performance validation
- Regulatory documentation

**Earliest Deployment:** 4-6 months

### Realistic Path (Full Retraining)

Add 2-4 weeks for feature generation and retraining  
**Earliest Deployment:** 5-7 months

### Conservative Path (External Validation)

Add 3-6 months for external validation study  
**Earliest Deployment:** 8-12 months

---

## 10. FINAL RECOMMENDATION

### DO NOT DEPLOY in current state

**Rationale:**
1. **Critical gaps exist:** No calibration, no baseline comparison
2. **Incomplete dataset:** Only 46.6% of expected training data
3. **No prospective validation:** Retrospective only insufficient
4. **Clinical integration unclear:** Workflow not designed

### RECOMMENDED PATH FORWARD

**Phase 1: Complete Critical Gaps (2-3 weeks)**
1. Perform calibration analysis
2. Implement and evaluate clinical baselines
3. Calculate confidence intervals
4. Perform early warning analysis
5. Make decision on full retraining

**Phase 2: Prepare for Deployment (3-4 weeks)**
1. Create deployment package
2. Implement test suite
3. Design clinical workflow
4. Create alert response protocols
5. Prepare training materials

**Phase 3: Shadow Mode (4-8 weeks)**
1. Deploy in non-interventional mode
2. Collect performance data
3. Gather clinician feedback
4. Refine based on real-world use

**Phase 4: Prospective Validation (8-16 weeks)**
1. Formal prospective study
2. IRB approval (if needed)
3. Data collection
4. Performance analysis
5. Regulatory documentation (if needed)

**Phase 5: Full Deployment (Ongoing)**
1. Live deployment with interventions
2. Continuous monitoring
3. Performance tracking
4. Periodic recalibration
5. Ongoing validation

**Total Timeline:** 6-12 months from current state

---

## 11. SUCCESS CRITERIA FOR GO/NO-GO DECISION

### Minimum Performance Thresholds

**Discrimination:**
- AUROC ≥ 0.75 (current: 0.787 ✓)
- AUPRC ≥ 0.04 (current: 0.058 ✓)

**Calibration:**
- ECE ≤ 0.05 (current: not calculated)
- MCE ≤ 0.15 (current: not calculated)

**Baseline Comparison:**
- Outperform SIRS/qSOFA on at least 2 of 3 metrics (AUROC, AUPRC, F1)
- Statistical significance (p < 0.05)

**Clinical Utility:**
- Alert rate ≤ 5% of observations (current: ~2.6% ✓)
- Precision ≥ 8% (current: ~10% ✓)
- Sensitivity ≥ 15% at high specificity (current: 18.4% ✓)

### GO Decision Criteria

**ALL of the following must be true:**
1. ✓ Technical performance meets thresholds (mostly met)
2. ❌ Calibration completed and meets criteria (not done)
3. ❌ Outperforms clinical baselines (not tested)
4. ❌ Prospective validation confirms retrospective performance (not done)
5. ❌ Clinical workflow successfully integrated (not done)
6. ❌ Clinicians trained and accepting (not done)

**Current Status:** 1 of 6 criteria met (17%)

---

## 12. CONCLUSION

### Current State

ICU Sentinel has achieved **moderate technical success** with models that generalize well and show stable performance. However, **critical validation and deployment gaps** prevent any deployment consideration at this time.

### Key Achievements

✓ Successfully trained three models on substantial dataset  
✓ Achieved good discrimination (AUROC 0.787)  
✓ Zero data leakage verified  
✓ Stable validation-to-test performance  
✓ Comprehensive documentation generated  

### Key Gaps

❌ No calibration (critical blocker)  
❌ No clinical baseline comparison (critical blocker)  
❌ Incomplete training dataset (46.6% of expected)  
❌ No prospective validation  
❌ Deployment package not ready  

### Final Verdict

**Status:** **NOT READY FOR DEPLOYMENT**

**Path to Deployment:** 6-12 months with proper completion of all validation steps

**Immediate Priority:** Complete calibration and baseline comparisons (2-3 weeks)

**Long-term Priority:** Prospective validation in clinical setting (essential for deployment)

### Stakeholder Communication

**To Management:**
- Models show promise but require 6-12 months additional work
- Critical validation gaps must be closed
- Budget/timeline expectations should be adjusted

**To Clinical Partners:**
- Performance moderate, cannot replace clinical judgment
- Would serve as early warning layer only
- Requires clinical workflow integration and training
- Need prospective validation before deployment

**To Developers:**
- Complete calibration analysis immediately (top priority)
- Implement clinical baseline comparisons
- Package deployment-ready pipeline
- Create comprehensive test suite

---

## APPENDIX: COMPLETE STATUS CHECKLIST

### Data & Features ⚠️  46.6% Complete

- [✓] Raw data downloaded (39,810 patients)
- [⚠️] Feature generation (18,543 of 39,810 patients, 46.6%)
- [✓] Train/val/test split (70/10/20, stratified)
- [✓] Zero patient overlap verified
- [✓] Features causal (no temporal leakage)

### Model Training ✓ Complete

- [✓] Extra Trees trained
- [✓] LightGBM trained
- [✓] XGBoost trained
- [✓] Hyperparameters configured
- [✓] Class weights balanced

### Model Validation ⚠️  Partial

- [✓] Validation metrics calculated
- [✓] Thresholds optimized (F1-based)
- [✓] Model comparison performed
- [✓] LightGBM selected
- [❌] Calibration performed
- [❌] Confidence intervals calculated
- [❌] Clinical baselines compared

### Model Testing ⚠️  Done But Uncalibrated

- [✓] Test metrics calculated
- [✓] Performance consistent with validation
- [❌] Tested with calibrated models
- [❌] Confidence intervals calculated
- [❌] Statistical significance tested
- [❌] Subgroup analysis performed

### Deployment Preparation ❌ Not Ready

- [✓] Models saved (joblib)
- [✓] Metadata documented
- [❌] Calibrated models saved
- [❌] Preprocessing packaged
- [❌] Inference API created
- [❌] Deployment package ready
- [❌] Monitoring implemented

### Validation Studies ❌ Not Done

- [✓] Internal validation (retrospective)
- [❌] Prospective validation
- [❌] External validation
- [❌] Clinical workflow testing
- [❌] Clinician acceptance testing

### Documentation ✓ Complete

- [✓] Model documentation
- [✓] Validation reports
- [✓] Gap analysis
- [✓] Readiness assessment
- [⚠️] Deployment guide (partial)
- [❌] Clinical protocol
- [❌] Training materials

**Overall Completion: ~40%**

---

**Report Generated:** 2026-11-09  
**Report Version:** 1.0  
**Next Review:** After calibration and baseline comparisons completed  

**Contact:** ICU Sentinel Project Team  
**Status:** PROJECT INCOMPLETE - DEPLOYMENT NOT RECOMMENDED
